Exporting Healthcare Equipment & Pharmaceuticals to Peru

Peru's healthcare sector is undergoing a significant transformation, driven by rising demand for quality medical services, an aging population, and increased government investment in public health infrastructure. For US exporters of healthcare equipment and pharmaceuticals, this presents a compelling opportunity. Peru relies heavily on imports for advanced medical devices and specialized pharmaceuticals, and the United States is already a leading supplier. This page provides a strategic overview for US companies looking to enter or expand in the Peruvian market, covering market size, import procedures, key buyers, and the competitive advantages of US-made products.

Local Market Size and Demand for Healthcare Equipment & Pharmaceuticals

Peru's healthcare expenditure has grown steadily, reaching approximately 5.5% of GDP in recent years, according to the World Bank. The country's medical device market was valued at around $1.2 billion in 2023, with imports accounting for over 80% of total consumption. Key demand drivers include the expansion of the public health network (e.g., EsSalud and MINSA hospital upgrades), a rise in chronic diseases such as diabetes and hypertension, and a growing private healthcare sector catering to a more affluent urban population. Pharmaceuticals represent another major segment: Peru's pharmaceutical market was estimated at $2.8 billion in 2023, with imported drugs making up roughly 60% of sales. The government's Universal Health Coverage initiative has further boosted demand for essential medicines, vaccines, and diagnostic equipment. US medical technology, including imaging devices (MRI, CT scanners), surgical instruments, and hospital furniture, is particularly sought after for its reliability and advanced features.

Import Process: How Products Enter Peru

Importing healthcare equipment and pharmaceuticals into Peru requires navigating a regulatory framework overseen by the General Directorate of Medicines, Supplies and Drugs (DIGEMID) under the Ministry of Health. For medical devices, registration with DIGEMID is mandatory, involving a technical file submission, quality certifications (such as ISO 13485 or FDA clearance), and a local authorized representative. The process can take 3 to 6 months. Pharmaceuticals require sanitary registration, which includes bioequivalence studies for generics and clinical trial data for new drugs. Import duties on medical devices range from 0% to 6%, while pharmaceuticals generally enter duty-free under Peru's tariff schedule. The US-Peru Trade Promotion Agreement (PTPA) provides preferential access, eliminating tariffs on most medical devices and many pharmaceutical products, provided they meet rules of origin. Customs clearance requires a bill of lading, commercial invoice, packing list, and sanitary certificate from DIGEMID. US exporters should work with a licensed customs broker and ensure labeling complies with Spanish-language requirements, including instructions for use and expiration dates.

Key Buyers and Distributors in Peru

The Peruvian healthcare market is concentrated in Lima, but regional hospitals and clinics are expanding. Major buyers include the Ministry of Health (MINSA) and its network of public hospitals, EsSalud (the social security health system), and large private hospital groups such as Clínica Ricardo Palma, Clínica Anglo Americana, and Clínica San Pablo. Public procurement is conducted through open tenders published on the state contracting platform OSCE (Organismo Supervisor de las Contrataciones del Estado). For pharmaceuticals, key distributors include firms like Droguería Inti, Farmindustria, and Droguería Alemana, which supply both public and private pharmacies. US companies should consider partnering with established local distributors who have DIGEMID registration experience and existing relationships with hospital purchasing departments. Trade shows such as TecnoSalud Peru and Expomed Peru are excellent venues for networking and showcasing products.

US Supplier Advantages for Healthcare Equipment & Pharmaceuticals in Peru

US-made healthcare equipment and pharmaceuticals enjoy a strong reputation in Peru for quality, innovation, and regulatory compliance. The US-Peru Trade Promotion Agreement (PTPA) provides a significant competitive edge by eliminating tariffs on most medical devices and pharmaceuticals, reducing costs for Peruvian buyers compared to suppliers from countries without such agreements. Additionally, US companies benefit from the FDA's stringent oversight, which is often recognized by DIGEMID as equivalent to high manufacturing standards, expediting registration for certain products. Technical support, after-sales service, and training are valued by Peruvian healthcare providers, offering US suppliers a differentiation advantage over lower-cost Asian competitors. The proximity of the US to Peru also enables faster shipping times and easier logistics, particularly for time-sensitive pharmaceuticals and high-value equipment.

Coppermont Advisory for US Exporters

Coppermont specializes in guiding US healthcare equipment and pharmaceutical companies through the complexities of exporting to Latin America. For Peru, we offer end-to-end support: from market assessment and regulatory mapping to distributor identification and post-entry compliance. Our team has deep experience with DIGEMID registration, PTPA tariff classification, and public procurement processes. We help US suppliers navigate the nuances of Peruvian business culture, build relationships with key buyers, and structure competitive offers for tenders. Whether you are a manufacturer of diagnostic imaging systems, surgical instruments, or specialty pharmaceuticals, Coppermont provides the strategic advisory needed to enter and grow in Peru's dynamic healthcare market. Contact us today to discuss your export potential.

Weighing this market or sourcing decision?

Coppermont works with a small number of clients at a time on exactly this kind of market entry and sourcing question. If it is relevant to what you are evaluating, we would welcome a conversation.

Talk to an advisor